Yarrow Bioscience Inc (YARW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$30.05

From 52W high−36.53%

Volume156504.00

Market cap$78.20M

P/E (TTM)—

P/S (TTM)162.2x

Div yield0.03%

Key dataSep 18, 2026

Open

$30.05

From 52W high

−36.53%

Volume

156504.00

Market cap

$78.20M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.9x

P/E (TTM)

—

RSI (14)

45.9

MomentumView details →

1D Return

−4.22%

YTD Return

+5.79%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.9x

EV/Sales

114.7x

P/S (TTM)

162.2x

P/B (TTM)

3.5x

ProfitabilityView details →

Gross Margin

97.51%

Net Margin

−3881.54%

EBITDA Margin

−3909.96%

ROE (TTM)

−84.80%

ROA (TTM)

−79.26%

Asset Turnover

0.02x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+6.12%

EPS CAGR 3Y

+33.80%

EBITDA YoY

—

MomentumView details →

1D Return

−4.22%

YTD Return

+5.79%

1Y Return

+101.78%

RSI (14)

45.9

vs 50D SMA

−13.49%

vs 200D SMA

−1.99%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

15.26x

Quick Ratio

15.26x

Div Yield

0.03%

Div Rate

$0.01

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.14

EPS Surprise

80.55%

Beats (12Q)

1/12

Next Q EPS Est

−$16.00

Avg Surprise (4Q)

80.55%

Rev Surprise

−51.50%

Financials snapshotView financials →

Revenue (TTM)

482000.00

Net Income (TTM)

−18.71M

Op. CF (TTM)

−16.93M

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for YARW.

Similar companies

Acrivon Therapeutics, Inc. Common StockACRV Gain Therapeutics, Inc.GANX Verrica Pharmaceuticals Inc.VRCA RenovoRx, Inc.RNXT Cingulate Inc.CING China Regenerative Medicine International Limited08158.HK Find similar companies →

Latest newsMore news →

No recent news for YARW.